Markets:

Overview

News

Currencies

International

Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

4.360 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

23 24 Next >

Could Iovance Biotherapeutics Stock Help You Become a Millionaire? ↗

March 02, 2024

Does Iovance Biotherapeutics stock possess enough upside to generate life-changing returns for your portfolio?

Via The Motley Fool

Iovance Biotherapeutics to Present at Upcoming Conferences

March 01, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

(IOVA) - Analyzing Iovance Biotherapeutics's Short Interest ↗

March 01, 2024

Via Benzinga

Why Iovance Biotherapeutics Stock Got Trounced on Thursday ↗

February 29, 2024

A robust rally ended abruptly with the publication of the company's latest fundamentals.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

February 29, 2024

Via Benzinga

Spotlight on Iovance Biotherapeutics: Analyzing the Surge in Options Activity ↗

February 29, 2024

Via Benzinga

Iovance Biotherapeutics: Q4 Earnings Insights ↗

February 28, 2024

Via Benzinga

Iovance Biotherapeutics's Earnings: A Preview ↗

February 27, 2024

Via Benzinga

Is Iovance a Buy After Its First Regulatory Win? ↗

February 25, 2024

Iovance Biotherapeutics has found a new way to treat cancer.

Via The Motley Fool

Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy? ↗

February 29, 2024

More gains might be on the way for this high-flying biotech stock.

Via The Motley Fool

Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

February 28, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

3 Stocks Flashing Recent Insider Buying Signals ↗

February 27, 2024

One way to spot an opportunity is by paying attention to insider buying stocks. After all, it’s the insiders that know their company.

Via InvestorPlace

3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024 ↗

February 26, 2024

Find out which under-the-radar biotech stocks have major catalysts on the horizon, and unlock their explosive growth potential.

Via InvestorPlace

1 Soaring Growth Stock That Could Rise Another 53%, According to Wall Street ↗

February 26, 2024

A successful launch of its first approved therapy could push shares of this innovative new cancer drug developer through the roof.

Via The Motley Fool

Unpacking the Latest Options Trading Trends in Iovance Biotherapeutics ↗

February 23, 2024

Via Benzinga

Iovance Biotherapeutics Unusual Options Activity For February 22 ↗

February 22, 2024

Via Benzinga

Why Iovance Biotherapeutics Stock Is Skyrocketing Today ↗

February 20, 2024

Iovance is no longer a clinical-stage biotech.

Via The Motley Fool

This Biotech Stock Has 47% Upside, According to 1 Wall Street Analyst ↗

February 23, 2024

It has good news in hand and plenty of room to grow.

Via The Motley Fool

2 Top Biotech Stocks That Wall Street Thinks Could Soon Double in Value ↗

February 23, 2024

These two businesses have viable paths to making investors richer -- possibly soon.

Via The Motley Fool

Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024

February 22, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential ↗

February 22, 2024

MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months.

Via Talk Markets

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 21, 2024

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 21, 2024

Via Benzinga

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) Near Top of Volume Charts in Wednesday Trading

February 21, 2024

Via Investor Brand Network

Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday ↗

February 21, 2024

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 20, 2024

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

Via Benzinga

Why Is Iovance Therapeutics (IOVA) Stock Up 35% Today? ↗

February 20, 2024

With Iovance Therapeutics gaining FDA approval for its novel skin cancer therapeutic, IOVA stock is proving the bears wrong.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 20, 2024

Via Benzinga

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) Near Top of Volume Charts in Tuesday Trading

February 20, 2024

Via Investor Brand Network

Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday ↗

February 20, 2024

U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.

Via Benzinga

Topics Stocks

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.